As the fourth quarter market in A-shares kicks off, the footprints of overseas institutions are forming a clear roadmap for investment positioning. According to data statistics, since October, 164 overseas institutions have collectively investigated 15 listed companies, with a focus on the electric power equipment and electronic technology sectors. By industry, overseas institutions primarily favor the electric power equipment, electronics, and machinery equipment sectors, with 5, 3, and 3 companies surveyed, respectively. The computer and biopharmaceutical industries follow, with 2 listed companies investigated in each. In terms of the number of investigations by overseas institutions, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760), Rongbai Technology, and Guangli Microelectronics lead the pack, with 124, 8, and 7 investigations, respectively.
During the institutional investigation, Shenzhen Mindray revealed that "Qiyuan," as the "AI intelligent agent" within the company’s "equipment + IT + AI" smart medical ecosystem, has achieved a significant breakthrough in medical artificial intelligence cognitive abilities. The Qiyuan critical care large model, set to be launched in December 2024, marks a significant first step for the company in the ICU department. Following this, the introduction of the Qiyuan perioperative medical large model further enhances the company’s layout in the critical care rescue chain.
Rongbai Technology stated during the investigation that the company has established production capacity for ternary cathode materials in Korea and Poland, with a precursor production line of 6,000 tons/year built in Korea. The export control measures target battery cells with an energy density of over 300Wh/kg, primarily involving ultra-high nickel, semi-solid, and solid-state batteries, while the company’s existing ternary and lithium iron phosphate battery products are unaffected. The battery products currently supplied do not involve restricted types, and the industry chain operates normally. The Korean factory is being constructed per customer demand and is currently ramping up production capacity. Lithium iron phosphate will enter the market with new technology, suitable for power batteries and high-end energy storage; the lithium-rich manganese-based technology is industry-leading, and the company will achieve industrialization the fastest.
From a market perspective, stocks under investigation by overseas institutions have performed well this year, with an average increase of 70.12%. Fourteen stocks have seen price increases, with Zhenyu Technology, Rejing Biopharmaceuticals, and Tengjing Technology leading the surge, rising by 243.48%, 186.74%, and 137.95%, respectively.
Zhenyu Technology belongs to the electric power equipment sector and is associated with popular concepts like new energy vehicles, lithium batteries, and humanoid robots. In terms of product advancements in the robot hardware field, the company stated during the institutional investigation that it continues to iterate on system integration based on the industrialization of component products, accelerating iterations of the reverse-style planetary roller screw – linear actuator module – highly integrated bionic arm through continuous improvement of processing techniques. Considering customer needs for machine weight reduction and heat generation, the company has iterated to a third-generation product that is 22.5% lighter than the previous generation, with surface temperatures of the installed actuators reduced by 13%, and has achieved capacity for large-scale production; the module’s volume has shrunk by more than 30% compared to the previous generation; the next generation of highly integrated modules is under development and is expected to be launched in the market in the second half of the year.
Stocks under investigation by overseas institutions are also favored by financing. As of October 15, 11 stocks have seen net financing purchases in October, with Shenzhen Mindray, Zhenyu Technology, and Dike shares leading in net purchase amounts of 589 million yuan, 125 million yuan, and 52 million yuan, respectively. Rongbai Technology and Sifangda also ranked high in net purchases, each exceeding 20 million yuan.
Comments